Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 06/29/17
Due: 06/29/18
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 10/31/24
End: 10/31/26
Due: 10/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety Evaluation of 3K3A-APC in Ischemic Stroke | NCT02222714 | ZZ Biotech, LLC | user2@example.com | None | 2014-10-31 | 2017-06-29 | 2018-06-29 | - | - | 2025-07-14 |
| Safety and Pharmacokinetics of Single and Multiple Ascending Doses of 3K3A-APC in Healthy Adult Volunteers | NCT01660230 | ZZ Biotech, LLC | user2@example.com | None | 2012-08-31 | 2012-12-31 | 2013-12-31 | - | - | 2025-07-14 |
| Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke | NCT05484154 | ZZ Biotech, LLC | user2@example.com | None | 2024-10-31 | 2026-10-31 | 2027-10-31 | - | - | 2025-07-14 |